Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for acute neuroleptic-induced akathisia
IRCT20191218045795N7Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of cyproheptadine in akathisia (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoint: Akathisia. Started Mar 2023; status: completed.
02
Drugs
cyproheptadine
03
Conditions
akathisia
Beyond the preview
Go deeper on IRCT20191218045795N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191218045795N7.